Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis

Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis

Thyroid-stimulating hormone (TSH) is a growth factor associated with the initiation and progression of well-differentiated thyroid cancer (WDTC). Atypia of undetermined significance and follicular lesion of undetermined significance (AUS/FLUS) are the most uncertain cytological diagnoses of thyroid...

Full description

Bibliographic Details
Main Authors:	Krzysztof Kaliszewski, Dorota Diakowska, Marta Rzeszutko, Łukasz Nowak, Beata Wojtczak, Krzysztof Sutkowski, Maksymilian Ludwig, Bartłomiej Ludwig, Agnieszka Mikuła, Maria Greniuk, Urszula Tokarczyk, Jerzy Rudnicki
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Biomedicines
Subjects:	thyroid-stimulating hormone TSH atypia of undetermined significance follicular lesion of undetermined significance AUS/FLUS thyroid cancer
Online Access:	https://www.mdpi.com/2227-9059/10/8/1916

Similar Items

Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
by: Taner Bayraktaroğlu, et al.
Published: (2023-06-01)

Atypia and Follicular Lesions of Undetermined Significance in Subsequent Biopsy Result: What Clinicians Need to Know
by: Krzysztof Kaliszewski, et al.
Published: (2021-07-01)

Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology
by: Kaliszewski K, et al.
Published: (2018-07-01)

Morphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance
by: Youngjin Kang, et al.
Published: (2016-07-01)

Weighty Matters: The Obesity–Thyroid Nodule Connection Unveiling the Impact of Obesity on Thyroid Cancer Risk
by: Saad M. Alqahtani, et al.
Published: (2023-09-01)

Molecular markers as risk factors for thyroid cancer
by: M O Rogova, et al.
Published: (2019-10-01)

Thyroid bethesda atypia of undetermined significance or follicular lesion of undetermined significance (aus/flus): A heterogenous group
by: Priyanka Maity, et al.
Published: (2019-01-01)

Atypia of Undetermined Significance in Thyroid Fine-Needle Aspiration Cytology: Pathological Evaluation and Risk Factors for Malignancy
by: Şafak Akın, et al.
Published: (2017-09-01)

Malignancy rate in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance - An institutional experience
by: Smita Chandra, et al.
Published: (2017-01-01)

Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance
by: Hamdan Ahmed Pasha, et al.
Published: (2020-01-01)

The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules
by: Saad M. Alqahtani, MD, et al.
Published: (2023-06-01)

Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation
by: Roope Huhtamella, et al.
Published: (2019-10-01)

Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients
by: Yoon Young Cho, et al.
Published: (2021-09-01)

The Correlation of Age with Prognosis of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodules
by: Kaliszewski K, et al.
Published: (2021-04-01)

Risk of malignancy in thyroid nodules classified as Bethesda categories III, III - subcategories and IV: 2.5 years study
by: Abeer M Ilyas, et al.
Published: (2023-01-01)

Is subdivision of Atypia of Undetermined Significance AUS/Follicular lesion of undetermined significance cases according to detailed nuclear features vital for assessing the risk of malignancy?
by: Esin Kaymaz, et al.
Published: (2020-01-01)

Risk of malignancy in Thyroid “Atypia of undetermined significance/Follicular lesion of undetermined significance” and its subcategories – A 5-year experience
by: Abha Thakur, et al.
Published: (2019-01-01)

Prospective study of bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation
by: Shiga Rappai Chirayath, et al.
Published: (2019-01-01)

Intraoperative Assessment of High-Risk Thyroid Nodules Based on Electrical Impedance Measurements: A Feasibility Study
by: Jalil Beheshti Firoozabadi, et al.
Published: (2022-11-01)

Core Needle Biopsy Is a More Conclusive Follow-up Method Than Repeat Fine Needle Aspiration for Thyroid Nodules with Initially Inconclusive Results: A Systematic Review and Meta-Analysis
by: Jung-Soo Pyo, et al.
Published: (2016-05-01)

Comparison of the Results of Thyroidectomy and Second Fine-Needle Aspiration Biopsy of the Old Age Group with the Previous Bethesda III group: Is the second Biopsy necessary?
by: Volkan Atmış, et al.
Published: (2020-01-01)

Presurgical screening of fine needle aspirates from thyroid nodules for BRAF mutations: A prospective single center experience
by: Ramamoorthy Hemalatha, et al.
Published: (2018-01-01)

Rate of malignancy for thyroid nodules with AUS/FLUS cytopathology in a tertiary care center – a retrospective cohort study
by: Kalpesh Hathi, et al.
Published: (2021-10-01)

Evaluation of Serum Neutrophil to Lymphocyte Ratio in The Results of Thyroid Fine Needle Aspiration: Can It Discriminate A Clinical Benefit for the Atypia of Undetermined Significance?
by: Özlem Özdemir, et al.
Published: (2021-10-01)

A pragmatic approach to the indeterminate thyroid nodule
by: Krishna G Seshadri
Published: (2017-01-01)

Cytologic assessment of thyroid nodules – Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls
by: Xiaobing Jin, et al.
Published: (2024-06-01)

Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS
by: Dorota Słowińska-Klencka, et al.
Published: (2022-09-01)

May 25-31, International thyroid awareness week & May 25, world thyroid day, 2022: Indetermination of indeterminate cytology, aus/flus, fn, susp, in thyroidology?
by: Sengul Ilker, et al.
Published: (2022-09-01)

Recurrence of paraproteinemic crystalline keratopathy after corneal transplantation: A case of monoclonal gammopathy of ocular significance
by: Siamak Nobacht, et al.
Published: (2020-09-01)

Type-I Cryoglobulinaemia Associated to Monoclonal Gammapathy of Undetermined Significance
by: Juan Manuel Duarte, et al.
Published: (2020-10-01)

Poems syndrome: The rare endocrinopathy
by: Miletić Marija, et al.
Published: (2024-01-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Oral, periorbital, and inguinal purpura in a patient with paraproteinemia
by: Donn LaTour, BS, et al.
Published: (2022-09-01)

Idiopathic Hypereosinophilia: A Multicenter Retrospective Analysis
by: Rhyou HI, et al.
Published: (2022-12-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

Renal confined sarcoidosis: Natural history and diagnostic challenge
by: Azam Ghafoor, et al.
Published: (2014-04-01)

The Use of Artificial Intelligence in the Diagnosis and Classification of Thyroid Nodules: An Update
by: Maksymilian Ludwig, et al.
Published: (2023-01-01)

Serum levels of TSH and thyroid hormones after TRH adminitration in the reindeer
by: V. Ojutkangas, et al.
Published: (1990-09-01)

A case of immunotactoid glomerulopathy with false-negative IgG staining
by: Shuma Hirashio, et al.
Published: (2018-06-01)

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
by: Shilpa Thakur, et al.
Published: (2019-09-01)